Araştırma Makalesi

Evaluation of Percutaneous Tracheostomy Cases at An Tertiary Care Center Intensive Care Unit

Cilt: 3 Sayı: 3 31 Aralık 2019
PDF İndir
EN TR

Evaluation of Percutaneous Tracheostomy Cases at An Tertiary Care Center Intensive Care Unit

Öz

Aim: Percutaneous tracheostomy is frequently performed in intensive care units, especially in patients requiring long-term mechanical ventilatory support.  It has advantages such as providing safe airway, facilitating the aspiration of the airways and reducing the length of stay in the intensive care unit. In this study, we aimed to retrospectively evaluate the percutaneous tracheostomy cases that we opened with the seldinger method at a tertiary care center intensive care unit.

Materials and Methods: Our study was performed retrospectively. The records of 78 patients who underwent percutaneous tracheostomy between June 15, 2016 and August 30, 2018 were included. Patients with surgical and local infection at the intervention site, short neck and large thyroid tissue, cervical vertebra fracture or neck extension restriction, morbid obese and patients under 18 years of age were excluded from the study.

Results: 78 patients were included in our study. the mean length of stay in the ICU was 39 days; mean duration of tracheostomy was 16.3 days. Most of the patients were admitted to intensive care unit due to serbrovascular and cardiovascular diseases. . Hypotension was detected in four patients after tracheostomy, while wound infection and subcutaneous emphysema were found in one patient.

Conclusion: Percutaneous tracheostomy is an easy method that can be applied to bedside in a short time in patients who need mechanical ventilation for a long time. Intubation and prolonged mechanical ventilator is a useful method that is frequently used in intensive care patients because it reduces side effects, improves patient comfort and facilitates patient care. Complications can be minimized if appropriate patient selection is performed by an experienced physician.

Anahtar Kelimeler

Destekleyen Kurum

yok

Teşekkür

yok

Kaynakça

  1. 1. Friedman Y. Percutaneous versus surgical tracheostomy: The continuing saga. Crit Care Med 2006; 34(8): 2250-1
  2. 2. Kost KM. Endoscopic percutaneous dilatational tracheotomy: a prospective evaluation of 500 consecutive cases. Laryngoscope 2005; 115: 1-30.
  3. 3. Sağıroğlu AE, Ağkoç E, Doğan Y, et al. Comparison of percutaneus and surgical tracheos- tomy in ICU [Article in Turkish]. Göztepe Tıp Dergisi 2010;25:67–70
  4. 4. Al-Ansari MA, Hijazi MH. Clinical review: percutaneous dilatational tracheostomy. Crit Care 2006; 10: 202.
  5. 5. Cabrini L, Bergonzi PC, Mamo D, et al. Dilatative percutaneous tracheostomy during doub- le antiplatelet therapy: two consecutive cases. Minerva Anestesiol 2008; 74: 565-7.
  6. 6. Friedman Y. Percutaneous versus surgical tracheostomy: The continuing saga. Crit Care Med 2006; 34(8): 2250-1
  7. 7. Rumbak MJ, Newton M, Truncale T,et al. A prospective, randomized, study comparing early percutaneous dilational tracheotomy to prolonged translaryngeal intubation (delayed tracheotomy) in critically ill medical patients. Crit Care Med 2004; 32: 1689-94.
  8. 8. Yıldırım F , Güllü YT, Demirel CB. Yoğun Bakımda Perkütan Trakeostomi. Eurasian J Pulmonol 2015 DOI: 10.5152/ejp.2014.27247.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Klinik Tıp Bilimleri

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

31 Aralık 2019

Gönderilme Tarihi

18 Kasım 2019

Kabul Tarihi

28 Kasım 2019

Yayımlandığı Sayı

Yıl 2019 Cilt: 3 Sayı: 3

Kaynak Göster

APA
Ece, C. (2019). Evaluation of Percutaneous Tracheostomy Cases at An Tertiary Care Center Intensive Care Unit. Journal of Biotechnology and Strategic Health Research, 3(3), 245-249. https://doi.org/10.34084/bshr.647658
AMA
1.Ece C. Evaluation of Percutaneous Tracheostomy Cases at An Tertiary Care Center Intensive Care Unit. J Biotechnol and Strategic Health Res. 2019;3(3):245-249. doi:10.34084/bshr.647658
Chicago
Ece, Cem. 2019. “Evaluation of Percutaneous Tracheostomy Cases at An Tertiary Care Center Intensive Care Unit”. Journal of Biotechnology and Strategic Health Research 3 (3): 245-49. https://doi.org/10.34084/bshr.647658.
EndNote
Ece C (01 Aralık 2019) Evaluation of Percutaneous Tracheostomy Cases at An Tertiary Care Center Intensive Care Unit. Journal of Biotechnology and Strategic Health Research 3 3 245–249.
IEEE
[1]C. Ece, “Evaluation of Percutaneous Tracheostomy Cases at An Tertiary Care Center Intensive Care Unit”, J Biotechnol and Strategic Health Res, c. 3, sy 3, ss. 245–249, Ara. 2019, doi: 10.34084/bshr.647658.
ISNAD
Ece, Cem. “Evaluation of Percutaneous Tracheostomy Cases at An Tertiary Care Center Intensive Care Unit”. Journal of Biotechnology and Strategic Health Research 3/3 (01 Aralık 2019): 245-249. https://doi.org/10.34084/bshr.647658.
JAMA
1.Ece C. Evaluation of Percutaneous Tracheostomy Cases at An Tertiary Care Center Intensive Care Unit. J Biotechnol and Strategic Health Res. 2019;3:245–249.
MLA
Ece, Cem. “Evaluation of Percutaneous Tracheostomy Cases at An Tertiary Care Center Intensive Care Unit”. Journal of Biotechnology and Strategic Health Research, c. 3, sy 3, Aralık 2019, ss. 245-9, doi:10.34084/bshr.647658.
Vancouver
1.Cem Ece. Evaluation of Percutaneous Tracheostomy Cases at An Tertiary Care Center Intensive Care Unit. J Biotechnol and Strategic Health Res. 01 Aralık 2019;3(3):245-9. doi:10.34084/bshr.647658